To confirm the results above, we then applied an interruption assay to see if blocking TIMP-1 to MMP2/MMP9 signals with neutralizing anti-TIMP-1 antibody might alter the TR4 ability to influence PCa invasion. The gene discussed is MMP9; the disease is posterior cortical atrophy.